Big Gain For Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc. (FULC:NASDAQ) shot up at $18.77, a gain of 125.3%. On Mon, Aug 09, 2021, FULC:NASDAQ touched a New 2-Week High of $8.33. The stock appeared on our News Catalysts scanner on Tue, Aug 10, 2021 at 07:52 AM in the 'EARNINGS' category. From Mon, Jul 26, 2021, the stock recorded 50.00% Up Days and 45.45% Green Days

The share price of the company has been moving sideways in recent weeks.

About Fulcrum Therapeutics, Inc. (FULC:NASDAQ)

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine which employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle wasting disorder that leads to physical impairments and disability.